Michael J. Goodheart

ORCID: 0000-0003-3498-8945 · 7 papers in corpus
2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.08.010

ObjectiveHigh-grade (HGOC) and low-grade ovarian carcinoma (LGOC) are distinct malignancies with different biological features, treatment paradigms, and life expectancies. However, differences in quality of life (QOL), sleep, and depressive…

2023
Cancers ·doi:10.3390/cancers15133316

There are strong correlations between the microbiome and human disease, including cancer. However, very little is known about potential mechanisms associated with malignant transformation in microbiome-associated gynecological cancer, excep…

2021
Cancers ·doi:10.3390/cancers13051109

Bacteria, archaea, and viruses are associated with numerous human cancers. To date, microbiome variations in transcription have not been evaluated relative to upper female genital tract cancer risk. Our aim was to assess differences in bact…

article 2015
·doi:10.1016/j.ygyno.2015.10.023

ObjectiveTo examine hormone receptor expression levels and downstream gene activation in pre-treatment and post-treatment biopsies in a cohort of patients with endometrial pathology who were being conservatively managed with a progestin-con…

article 2015
·doi:10.1016/j.ygyno.2015.07.079
article 2013
·doi:10.1016/j.ygyno.2013.04.272
2012
PloS one ·doi:10.1371/journal.pone.0040312

Endometrial carcinoma is the most common gynecologic cancer, yet the mechanisms underlying this disease process are poorly understood. We hypothesized that Lef1 is required for endometrial gland formation within the uterus and is overexpres…